Zevra Therapeutics Inc
Follow $ZVRA
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $ZVRA by emailVeridion Score
BETAMEDIUM CONF · 5 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is ZVRA moving today?
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
ZVRA overview
Related filings and maps
Congress activity in ZVRA
No receipt-qualified Congressional disclosure is present for ZVRA in the cached public ledger.
ZVRA contract awards, year to date.
Public federal awards linked to this ticker.
ZVRA lobbying filings, year to date.
Registered lobbying filings matched to Zevra Therapeutics Inc.